VGV-L

N/A

Report date: 2025/01/26 15:47:10

Base Information

Drug NameVGV-L
Drug Alias NameLyme disease therapy (VG Life Sciences)Lyme disease therapy (Viral Genetics)VGV-L
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionImmunostimulants
TargetsUpdating
Therapy Area/IndicationsLyme Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVg Life Sciences
China Registration ClassN/A

Develop Information

Active CompaniesVg Life Sciences
Inactive CompaniesN/A
Active IndicationsLyme Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A